Devon J. Dishman

Statistics

Publications

Citations

198

H-Index

Active since

2017

Affiliations

Virttu Biologics (United Kingdom)(Current)

Nationwide Children's Hospital

Devon J. Dishman is an author at Virttu Biologics (United Kingdom) specializing in oncolytic virus therapy, oncolytic viral therapy, and intratumoral administration.

Publications per year

2017–2019

Publications

Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients

Keri A. Streby, James I. Geller, Mark A. Currier et al. · Clinical Cancer Research · 2017 · 137 citations · Full text

Medicine, Immunology, Oncology +16

First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial

Keri A. Streby, Mark A. Currier, Melinda Triplet et al. · Molecular Therapy · 2019 · 61 citations · Full text

Pharmacy, Oncology, Pharmacology +16

1–2 of 2